Trials Underway Using Experimental CAR T-Cell Therapy For Deadly Childhood Brain Cancer

The trials being run at hospitals in Stanford and Seattle will evaluate the CAR T-cells in small numbers of patients to assess the feasibility and safety of the treatment.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: Healthcare /healthcare Innovation /innovation Science /science Editors' Pick editors-pick business pharma & Source Type: news